| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Transcatheter Aortic Valve Replacement | 26 | 2019 | 839 | 5.84 | Why? |
| Aortic Aneurysm, Abdominal | 9 | 2019 | 155 | 4.92 | Why? |
| Aortic Valve | 15 | 2019 | 664 | 3.75 | Why? |
| Aortic Aneurysm | 5 | 2019 | 121 | 3.04 | Why? |
| Heart Valve Prosthesis Implantation | 10 | 2019 | 552 | 2.71 | Why? |
| Aortic Rupture | 4 | 2017 | 64 | 2.55 | Why? |
| Coronary Artery Bypass | 8 | 2018 | 629 | 2.51 | Why? |
| Aneurysm, Dissecting | 5 | 2019 | 303 | 2.46 | Why? |
| Mitral Valve | 5 | 2019 | 342 | 2.34 | Why? |
| Heart Valve Prosthesis | 9 | 2019 | 533 | 1.98 | Why? |
| Coronary Artery Bypass, Off-Pump | 6 | 2018 | 27 | 1.98 | Why? |
| Aortic Valve Stenosis | 10 | 2019 | 741 | 1.88 | Why? |
| Aortic Valve Insufficiency | 3 | 2019 | 136 | 1.87 | Why? |
| Blood Group Antigens | 2 | 2020 | 202 | 1.36 | Why? |
| Heart Valve Diseases | 4 | 2019 | 355 | 1.36 | Why? |
| Ventricular Function, Left | 4 | 2019 | 1555 | 1.21 | Why? |
| Mitral Valve Insufficiency | 2 | 2018 | 302 | 1.02 | Why? |
| Coronary Artery Disease | 6 | 2018 | 2570 | 1.00 | Why? |
| Postoperative Complications | 14 | 2019 | 5861 | 0.90 | Why? |
| Prosthesis Failure | 2 | 2018 | 195 | 0.82 | Why? |
| Moon | 1 | 2019 | 8 | 0.82 | Why? |
| Cardiac Catheterization | 5 | 2018 | 882 | 0.77 | Why? |
| Vascular Surgical Procedures | 2 | 2018 | 882 | 0.74 | Why? |
| Psoas Muscles | 1 | 2018 | 28 | 0.74 | Why? |
| Tricuspid Valve | 1 | 2019 | 91 | 0.72 | Why? |
| Cold Temperature | 1 | 2019 | 260 | 0.71 | Why? |
| Periodicity | 1 | 2017 | 34 | 0.70 | Why? |
| Nicotine | 1 | 2020 | 213 | 0.68 | Why? |
| Fruit | 1 | 2019 | 313 | 0.68 | Why? |
| Physical Conditioning, Human | 1 | 2017 | 57 | 0.66 | Why? |
| Perfusion | 1 | 2018 | 254 | 0.66 | Why? |
| Vegetables | 1 | 2019 | 340 | 0.65 | Why? |
| Body Mass Index | 4 | 2019 | 4306 | 0.65 | Why? |
| Weather | 2 | 2020 | 581 | 0.65 | Why? |
| Mitral Valve Annuloplasty | 1 | 2016 | 35 | 0.65 | Why? |
| After-Hours Care | 1 | 2017 | 82 | 0.64 | Why? |
| Randomized Controlled Trials as Topic | 11 | 2020 | 10649 | 0.63 | Why? |
| Aorta, Abdominal | 1 | 2016 | 50 | 0.61 | Why? |
| Antifibrinolytic Agents | 1 | 2017 | 150 | 0.60 | Why? |
| Tranexamic Acid | 1 | 2017 | 121 | 0.60 | Why? |
| Aorta, Thoracic | 1 | 2018 | 271 | 0.59 | Why? |
| Cardiac Surgical Procedures | 3 | 2017 | 1931 | 0.58 | Why? |
| Blood Loss, Surgical | 1 | 2017 | 211 | 0.58 | Why? |
| Publications | 1 | 2020 | 463 | 0.58 | Why? |
| Diet, Mediterranean | 1 | 2019 | 351 | 0.57 | Why? |
| Risk Factors | 33 | 2020 | 71621 | 0.57 | Why? |
| Cerebrovascular Circulation | 1 | 2018 | 340 | 0.56 | Why? |
| Obesity | 5 | 2020 | 7388 | 0.56 | Why? |
| Anemia | 2 | 2019 | 789 | 0.55 | Why? |
| Hypertrophy, Left Ventricular | 1 | 2017 | 219 | 0.55 | Why? |
| Exercise Tolerance | 2 | 2019 | 634 | 0.54 | Why? |
| Drug-Eluting Stents | 2 | 2017 | 562 | 0.54 | Why? |
| Chi-Square Distribution | 4 | 2017 | 961 | 0.53 | Why? |
| Community Participation | 1 | 2020 | 605 | 0.52 | Why? |
| Stroke Volume | 3 | 2019 | 2153 | 0.51 | Why? |
| Aortic Diseases | 1 | 2018 | 362 | 0.51 | Why? |
| Exercise Therapy | 2 | 2019 | 976 | 0.50 | Why? |
| Hemoglobins | 1 | 2018 | 958 | 0.48 | Why? |
| Risk Assessment | 18 | 2020 | 25439 | 0.48 | Why? |
| Propensity Score | 8 | 2019 | 2690 | 0.47 | Why? |
| Hot Temperature | 1 | 2020 | 1299 | 0.47 | Why? |
| Social Class | 1 | 2020 | 1360 | 0.46 | Why? |
| Social Behavior | 1 | 2020 | 882 | 0.46 | Why? |
| Circadian Rhythm | 1 | 2017 | 607 | 0.44 | Why? |
| Robotic Surgical Procedures | 1 | 2019 | 787 | 0.44 | Why? |
| Peripheral Arterial Disease | 1 | 2017 | 471 | 0.43 | Why? |
| Exercise Test | 1 | 2017 | 911 | 0.43 | Why? |
| Treatment Outcome | 24 | 2020 | 51732 | 0.42 | Why? |
| Ultraviolet Rays | 1 | 2020 | 1272 | 0.42 | Why? |
| Odds Ratio | 6 | 2019 | 5861 | 0.42 | Why? |
| Observational Studies as Topic | 5 | 2018 | 1887 | 0.41 | Why? |
| Politics | 2 | 2020 | 1824 | 0.41 | Why? |
| Epidemics | 2 | 2020 | 6407 | 0.41 | Why? |
| Blood Transfusion | 2 | 2019 | 1399 | 0.41 | Why? |
| Myocardial Ischemia | 1 | 2016 | 781 | 0.39 | Why? |
| Time Factors | 17 | 2019 | 31397 | 0.39 | Why? |
| Arteriosclerosis | 1 | 2009 | 50 | 0.39 | Why? |
| Overweight | 1 | 2015 | 916 | 0.38 | Why? |
| Humans | 84 | 2021 | 930598 | 0.38 | Why? |
| Prosthesis Design | 4 | 2019 | 594 | 0.37 | Why? |
| Graft Occlusion, Vascular | 1 | 2009 | 105 | 0.36 | Why? |
| Seizures | 1 | 2017 | 1163 | 0.35 | Why? |
| Leg | 1 | 2009 | 142 | 0.35 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2010 | 1510 | 0.35 | Why? |
| Incidence | 14 | 2021 | 25622 | 0.34 | Why? |
| Blood Vessel Prosthesis Implantation | 1 | 2010 | 226 | 0.34 | Why? |
| Liver Cirrhosis | 1 | 2019 | 1810 | 0.33 | Why? |
| Bioprosthesis | 2 | 2018 | 126 | 0.33 | Why? |
| Endovascular Procedures | 1 | 2017 | 1302 | 0.32 | Why? |
| Prevalence | 8 | 2020 | 25773 | 0.32 | Why? |
| Hemodynamics | 4 | 2018 | 1562 | 0.32 | Why? |
| Atrial Fibrillation | 2 | 2019 | 2320 | 0.31 | Why? |
| Cardiotonic Agents | 1 | 2009 | 418 | 0.30 | Why? |
| Acute Coronary Syndrome | 1 | 2019 | 2107 | 0.30 | Why? |
| Aged | 35 | 2021 | 215776 | 0.29 | Why? |
| Aged, 80 and over | 22 | 2021 | 88759 | 0.28 | Why? |
| Travel | 2 | 2020 | 7220 | 0.28 | Why? |
| Recovery of Function | 4 | 2018 | 2461 | 0.28 | Why? |
| Percutaneous Coronary Intervention | 3 | 2018 | 3646 | 0.28 | Why? |
| Seasons | 1 | 2017 | 4071 | 0.27 | Why? |
| Regression Analysis | 3 | 2020 | 2484 | 0.27 | Why? |
| Heart Diseases | 2 | 2020 | 3503 | 0.26 | Why? |
| Coronary Stenosis | 1 | 2007 | 273 | 0.26 | Why? |
| Forecasting | 2 | 2018 | 4492 | 0.26 | Why? |
| Angioplasty, Balloon, Coronary | 1 | 2007 | 365 | 0.26 | Why? |
| Multivariate Analysis | 3 | 2020 | 5440 | 0.26 | Why? |
| Cognition Disorders | 1 | 2008 | 574 | 0.25 | Why? |
| Socioeconomic Factors | 1 | 2020 | 8495 | 0.24 | Why? |
| Health Status Disparities | 1 | 2020 | 4072 | 0.24 | Why? |
| Survival Rate | 6 | 2020 | 9206 | 0.24 | Why? |
| Cause of Death | 4 | 2021 | 4823 | 0.24 | Why? |
| Non-ST Elevated Myocardial Infarction | 2 | 2018 | 490 | 0.24 | Why? |
| Patient Selection | 1 | 2017 | 4560 | 0.23 | Why? |
| Male | 37 | 2021 | 367725 | 0.23 | Why? |
| Eyeglasses | 1 | 2021 | 43 | 0.22 | Why? |
| Ischemia | 1 | 2009 | 901 | 0.21 | Why? |
| Hospital Mortality | 10 | 2020 | 22087 | 0.21 | Why? |
| Antimetabolites | 1 | 2020 | 106 | 0.21 | Why? |
| Gravitation | 1 | 2019 | 20 | 0.21 | Why? |
| Patient Admission | 1 | 2017 | 5250 | 0.21 | Why? |
| Prodromal Symptoms | 1 | 2020 | 133 | 0.20 | Why? |
| Female | 34 | 2021 | 380317 | 0.20 | Why? |
| Pandemics | 9 | 2020 | 389249 | 0.20 | Why? |
| Femoral Artery | 2 | 2018 | 213 | 0.20 | Why? |
| Elective Surgical Procedures | 2 | 2018 | 5338 | 0.20 | Why? |
| Perioperative Period | 2 | 2017 | 276 | 0.19 | Why? |
| Prognosis | 9 | 2020 | 32490 | 0.19 | Why? |
| Evaluation Studies as Topic | 1 | 2020 | 391 | 0.19 | Why? |
| Failure to Rescue, Health Care | 1 | 2018 | 13 | 0.19 | Why? |
| Chronobiology Phenomena | 1 | 2017 | 9 | 0.18 | Why? |
| Tokyo | 1 | 2020 | 645 | 0.18 | Why? |
| Fourier Analysis | 1 | 2017 | 42 | 0.18 | Why? |
| Cities | 2 | 2020 | 4937 | 0.18 | Why? |
| Middle Aged | 24 | 2021 | 270681 | 0.17 | Why? |
| Databases, Bibliographic | 1 | 2018 | 182 | 0.17 | Why? |
| Radial Artery | 1 | 2018 | 132 | 0.17 | Why? |
| Muscle Stretching Exercises | 1 | 2017 | 25 | 0.17 | Why? |
| Organ Size | 1 | 2018 | 384 | 0.17 | Why? |
| Postoperative Hemorrhage | 1 | 2019 | 183 | 0.17 | Why? |
| Angina, Stable | 1 | 2017 | 45 | 0.17 | Why? |
| Oxidative Stress | 2 | 2019 | 2050 | 0.17 | Why? |
| Exercise | 1 | 2017 | 6771 | 0.16 | Why? |
| Least-Squares Analysis | 1 | 2017 | 254 | 0.16 | Why? |
| Platelet Aggregation Inhibitors | 2 | 2017 | 1671 | 0.16 | Why? |
| Health Resources | 1 | 2010 | 2592 | 0.16 | Why? |
| Proportional Hazards Models | 3 | 2019 | 6543 | 0.16 | Why? |
| Angina, Unstable | 1 | 2017 | 110 | 0.16 | Why? |
| Mass Screening | 1 | 2017 | 8005 | 0.16 | Why? |
| Nonlinear Dynamics | 1 | 2017 | 177 | 0.16 | Why? |
| Dilatation, Pathologic | 1 | 2016 | 78 | 0.16 | Why? |
| Quality of Life | 1 | 2017 | 9820 | 0.16 | Why? |
| United States | 12 | 2020 | 46150 | 0.15 | Why? |
| Meta-Analysis as Topic | 2 | 2017 | 1289 | 0.15 | Why? |
| Acute Disease | 2 | 2019 | 6029 | 0.15 | Why? |
| Reoperation | 1 | 2018 | 544 | 0.15 | Why? |
| Conjunctivitis, Viral | 1 | 2020 | 301 | 0.15 | Why? |
| Age Factors | 5 | 2020 | 21039 | 0.15 | Why? |
| Foramen Ovale, Patent | 1 | 2017 | 153 | 0.14 | Why? |
| Catheterization, Peripheral | 1 | 2018 | 249 | 0.14 | Why? |
| Myocardial Revascularization | 1 | 2017 | 267 | 0.14 | Why? |
| Hospital Costs | 4 | 2018 | 274 | 0.14 | Why? |
| Hospice and Palliative Care Nursing | 1 | 2018 | 235 | 0.14 | Why? |
| Catheter Ablation | 1 | 2019 | 438 | 0.14 | Why? |
| Protective Factors | 1 | 2020 | 1720 | 0.14 | Why? |
| Survival Analysis | 3 | 2020 | 7592 | 0.13 | Why? |
| Troponin | 1 | 2020 | 1058 | 0.13 | Why? |
| Clinical Decision-Making | 2 | 2018 | 3755 | 0.13 | Why? |
| Invasive Pulmonary Aspergillosis | 1 | 2021 | 634 | 0.13 | Why? |
| Oxygen Consumption | 1 | 2018 | 711 | 0.13 | Why? |
| Inpatients | 3 | 2020 | 5161 | 0.13 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.13 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.13 | Why? |
| Government Regulation | 1 | 2020 | 842 | 0.13 | Why? |
| Cardiac Rehabilitation | 1 | 2019 | 525 | 0.12 | Why? |
| Depression | 1 | 2017 | 14116 | 0.12 | Why? |
| Databases, Factual | 4 | 2020 | 6248 | 0.12 | Why? |
| Follow-Up Studies | 5 | 2021 | 17020 | 0.11 | Why? |
| Anxiety | 1 | 2017 | 17311 | 0.11 | Why? |
| Stroke | 3 | 2020 | 8839 | 0.11 | Why? |
| Income | 1 | 2020 | 1564 | 0.11 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.11 | Why? |
| Global Health | 4 | 2017 | 13911 | 0.10 | Why? |
| Defibrillators, Implantable | 1 | 2017 | 624 | 0.10 | Why? |
| Vascular Patency | 1 | 2009 | 96 | 0.10 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.09 | Why? |
| Comorbidity | 5 | 2020 | 34796 | 0.09 | Why? |
| Mucocutaneous Lymph Node Syndrome | 1 | 2021 | 1645 | 0.09 | Why? |
| Kaplan-Meier Estimate | 1 | 2018 | 4260 | 0.09 | Why? |
| Ventricular Dysfunction, Left | 1 | 2017 | 993 | 0.09 | Why? |
| Perioperative Care | 1 | 2019 | 1329 | 0.09 | Why? |
| Particulate Matter | 1 | 2020 | 3249 | 0.09 | Why? |
| Vascular Diseases | 1 | 2017 | 846 | 0.09 | Why? |
| Thromboembolism | 1 | 2020 | 2101 | 0.08 | Why? |
| World Health Organization | 1 | 2020 | 4213 | 0.08 | Why? |
| Lupus Erythematosus, Systemic | 1 | 2018 | 1380 | 0.08 | Why? |
| Smoking | 1 | 2020 | 3358 | 0.08 | Why? |
| Diabetes Mellitus | 3 | 2017 | 8207 | 0.08 | Why? |
| Mortality | 2 | 2020 | 7132 | 0.08 | Why? |
| Risk | 1 | 2018 | 5288 | 0.08 | Why? |
| Morbidity | 1 | 2012 | 1426 | 0.07 | Why? |
| Endothelium, Vascular | 1 | 2017 | 1751 | 0.07 | Why? |
| Sex Factors | 3 | 2017 | 11014 | 0.07 | Why? |
| Causality | 1 | 2009 | 857 | 0.07 | Why? |
| Echocardiography | 1 | 2019 | 3661 | 0.07 | Why? |
| Disease Progression | 3 | 2020 | 13580 | 0.07 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2020 | 3892 | 0.07 | Why? |
| Palliative Care | 1 | 2018 | 2665 | 0.07 | Why? |
| Neuropsychological Tests | 1 | 2008 | 954 | 0.06 | Why? |
| Adenosine Monophosphate | 1 | 2020 | 5652 | 0.06 | Why? |
| Alanine | 1 | 2020 | 5687 | 0.06 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.06 | Why? |
| Referral and Consultation | 1 | 2018 | 4816 | 0.06 | Why? |
| ST Elevation Myocardial Infarction | 1 | 2018 | 3051 | 0.06 | Why? |
| Spain | 1 | 2020 | 15545 | 0.06 | Why? |
| Minimally Invasive Surgical Procedures | 1 | 2007 | 663 | 0.06 | Why? |
| Adolescent | 4 | 2021 | 86841 | 0.06 | Why? |
| Logistic Models | 1 | 2016 | 9089 | 0.06 | Why? |
| Pulmonary Diffusing Capacity | 1 | 2021 | 191 | 0.05 | Why? |
| Length of Stay | 4 | 2018 | 11042 | 0.05 | Why? |
| Adult | 6 | 2021 | 244371 | 0.05 | Why? |
| Young Adult | 3 | 2020 | 93724 | 0.05 | Why? |
| Punctures | 1 | 2018 | 89 | 0.05 | Why? |
| Registries | 1 | 2018 | 12327 | 0.04 | Why? |
| Hospitals | 1 | 2017 | 11793 | 0.04 | Why? |
| Child | 3 | 2021 | 70012 | 0.04 | Why? |
| Muscle Strength | 1 | 2019 | 317 | 0.04 | Why? |
| Severity of Illness Index | 3 | 2020 | 48226 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Anticoagulants | 1 | 2017 | 9563 | 0.04 | Why? |
| Italy | 1 | 2020 | 38444 | 0.04 | Why? |
| Peripheral Vascular Diseases | 1 | 2017 | 133 | 0.04 | Why? |
| Heart Failure | 1 | 2017 | 6638 | 0.04 | Why? |
| Cost Savings | 1 | 2017 | 296 | 0.04 | Why? |
| Heart Atria | 1 | 2017 | 267 | 0.03 | Why? |
| Hospitals, Rural | 1 | 2017 | 185 | 0.03 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.03 | Why? |
| Respiratory Function Tests | 1 | 2021 | 1755 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2020 | 2324 | 0.03 | Why? |
| China | 1 | 2020 | 50654 | 0.03 | Why? |
| Pacemaker, Artificial | 1 | 2017 | 431 | 0.03 | Why? |
| Lung | 1 | 2021 | 31049 | 0.03 | Why? |
| Hospitals, Urban | 1 | 2017 | 950 | 0.03 | Why? |
| Stents | 1 | 2018 | 916 | 0.03 | Why? |
| Animals | 1 | 2020 | 78931 | 0.03 | Why? |
| DNA, Viral | 1 | 2020 | 2521 | 0.02 | Why? |
| Hospital Bed Capacity | 1 | 2017 | 1300 | 0.02 | Why? |
| Hospitals, Teaching | 1 | 2017 | 1609 | 0.02 | Why? |
| Extracorporeal Membrane Oxygenation | 2 | 2017 | 5002 | 0.02 | Why? |
| Recurrence | 1 | 2017 | 3675 | 0.02 | Why? |
| Cost-Benefit Analysis | 1 | 2017 | 2259 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Thrombolytic Therapy | 1 | 2018 | 2218 | 0.02 | Why? |
| Hemorrhage | 1 | 2017 | 3013 | 0.02 | Why? |
| Cohort Studies | 2 | 2018 | 36005 | 0.02 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2017 | 7268 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2018 | 9537 | 0.02 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.01 | Why? |
| Myocardial Infarction | 1 | 2017 | 3361 | 0.01 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 6653 | 0.01 | Why? |
| Sepsis | 1 | 2017 | 3517 | 0.01 | Why? |
| Biomarkers | 1 | 2020 | 23361 | 0.01 | Why? |
| Acute Kidney Injury | 1 | 2017 | 5762 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2021 | 25144 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Retrospective Studies | 1 | 2018 | 105322 | 0.00 | Why? |